학술논문
PRO29 COST-EFFECTIVENESS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE IN A DANISH SETTING
Document Type
Abstract
Author
Source
In Value in Health November 2019 22 Supplement 3:S846-S846
Subject
Language
ISSN
1098-3015